Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 350

1.

Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes.

Mantovani A, Rigolon R, Pichiri I, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Sep 20. pii: S1056-8727(17)30937-6. doi: 10.1016/j.jdiacomp.2017.09.011. [Epub ahead of print]

PMID:
29033310
2.

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.

Mantovani A, Rigolon R, Pichiri I, Bonapace S, Morani G, Zoppini G, Bonora E, Targher G.

PLoS One. 2017 Oct 5;12(10):e0185459. doi: 10.1371/journal.pone.0185459. eCollection 2017.

3.

NAFLD: Is There Anything New under the Sun?

Lonardo A, Targher G.

Int J Mol Sci. 2017 Sep 12;18(9). pii: E1955. doi: 10.3390/ijms18091955.

4.

A fatty liver leads to decreased kidney function?

Targher G, Francque SM.

J Hepatol. 2017 Sep 16. pii: S0168-8278(17)32258-4. doi: 10.1016/j.jhep.2017.08.018. [Epub ahead of print] No abstract available.

PMID:
28870673
5.

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Mantovani A, Targher G.

Ann Transl Med. 2017 Jul;5(13):270. doi: 10.21037/atm.2017.04.41. Review.

6.

Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose.

Carnevale R, Pastori D, Nocella C, Cammisotto V, Baratta F, Del Ben M, Angelico F, Sciarretta S, Bartimoccia S, Novo M, Targher G, Violi F.

Nutr Metab Cardiovasc Dis. 2017 Oct;27(10):890-895. doi: 10.1016/j.numecd.2017.06.007. Epub 2017 Jun 19.

PMID:
28743559
7.

Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Mantovani A, Rigolon R, Civettini A, Bolzan B, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Endocrinol Invest. 2017 Jul 15. doi: 10.1007/s40618-017-0729-4. [Epub ahead of print]

PMID:
28711969
8.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.

Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.

9.

Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.

Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, Lonardo A.

Metabolism. 2017 Jul;72:57-65. doi: 10.1016/j.metabol.2017.04.003. Epub 2017 Apr 13.

PMID:
28641784
10.

Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.

Violi F, Targher G, Vestri A, Carnevale R, Averna M, Farcomeni A, Lenzi A, Angelico F, Cipollone F, Pastori D.

Am Heart J. 2017 Jul;189:120-127. doi: 10.1016/j.ahj.2017.04.005. Epub 2017 Apr 18.

PMID:
28625368
11.

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Adams LA, Anstee QM, Tilg H, Targher G.

Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17. Review.

PMID:
28314735
12.

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.

Valbusa F, Bonapace S, Agnoletti D, Scala L, Grillo C, Arduini P, Turcato E, Mantovani A, Zoppini G, Arcaro G, Byrne C, Targher G.

PLoS One. 2017 Mar 13;12(3):e0173398. doi: 10.1371/journal.pone.0173398. eCollection 2017.

13.

Psychological distress, self-efficacy and glycemic control in type 2 diabetes.

Indelicato L, Dauriz M, Santi L, Bonora F, Negri C, Cacciatori V, Targher G, Trento M, Bonora E.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):300-306. doi: 10.1016/j.numecd.2017.01.006. Epub 2017 Jan 31.

PMID:
28274728
14.

Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function.

Zoppini G, Bergamini C, Bonapace S, Rossi A, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1035-1040. doi: 10.1016/j.jdiacomp.2017.01.021. Epub 2017 Feb 13.

PMID:
28258906
15.

Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.

Dauriz M, Targher G, Laroche C, Temporelli PL, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro M, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry.

Diabetes Care. 2017 May;40(5):671-678. doi: 10.2337/dc16-2016. Epub 2017 Mar 2.

PMID:
28255009
16.

Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.

Mantovani A, Rigolon R, Mingolla L, Pichiri I, Cavalieri V, Salvotelli L, Stoico V, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1021-1026. doi: 10.1016/j.jdiacomp.2017.01.024. Epub 2017 Feb 12.

PMID:
28254449
17.

Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.

Targher G, Byrne CD.

Nat Rev Nephrol. 2017 May;13(5):297-310. doi: 10.1038/nrneph.2017.16. Epub 2017 Feb 20. Review.

PMID:
28218263
18.

"Not all forms of NAFLD were created equal". Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?

Lonardo A, Ballestri S, Targher G.

Atherosclerosis. 2017 Feb;257:253-255. doi: 10.1016/j.atherosclerosis.2017.01.008. Epub 2017 Jan 18. No abstract available.

PMID:
28126321
19.

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G.

World J Gastroenterol. 2016 Nov 28;22(44):9674-9693. Review.

20.

Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes.

Bonapace S, Valbusa F, Bertolini L, Zenari L, Canali G, Molon G, Lanzoni L, Cecchetto A, Rossi A, Mantovani A, Zoppini G, Barbieri E, Targher G.

J Diabetes Complications. 2017 Feb;31(2):413-418. doi: 10.1016/j.jdiacomp.2016.10.032. Epub 2016 Nov 3.

PMID:
27884663

Supplemental Content

Loading ...
Support Center